Search

ACTAVALON ANNOUNCES APPOINTMENTS OF DR. JOHN HOOD TO ITS BOARD OF DIRECTORS

SAN DIEGO, Aug. 14, 2018 /PRNewswire/ - Actavalon, Inc., a preclinical-stage biotechnology company focused on developing small molecules...

Is modern medicine a form of death by design?

IS MODERN MEDICINE A FORM OF DEATH BY DESIGN?

It's not a secret that many pharmaceutical drugs are dangerous; the side effects listed on infomercials alone are proof of that. But...

 
 
 
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More

BIO ROUNDUP: MEDICARE DRUG PRICES, FDA MOVES, GENE THERAPY NEWS & MORE

Two imminent FDA rulings on two separate drugs aren't just noteworthy for the patients they'll help, but the long and winding road...

14TH INTERNATIONAL CONFERENCE ON GENERIC DRUGS AND BIOSIMILARS

Conference series takes pleasure in inviting the scientific community across the globe to attend the 14th International Conference...

 
 
 
 
 
 

SENIOR SAS PROGRAMMER - REDBOCK - ENCINITAS, CA

Senior Statistical Programmer - 10+ years of Statistical Programming experience in the Biotech/Pharmaceutical industry - CDISC (SDTM...From...

 
 
 

IRONWOOD ABANDONS DEAL WITH ASTRAZENECA FOR LESINURAD, ONCE HOPED TO BE A GOUT BLOCKBUSTER

Ironwood Pharmaceuticals has decided to walk away from its 2016 deal to license AstraZeneca's billion-dollar gout treatment lesinurad...

GMP/PHARMACEUTICAL PRODUCTION OPERATOR

Dow Development Laboratories is a contract topical drug product development service provider, with facilities located in Petaluma,...

 
 
 

GUEST EDITORIAL IEEE BIBM 2017 SPECIAL ISSUE

Bioinformatics and biomedicine research is fundamental to our understanding of complex biological systems, impacting the science and...

 
 
 

FINAL RESULTS FROM THE PROTAGONIST PROPEL STUDY SUPPORT FURTHER CLINICAL DEVELOPMENT OF PTG-100 FOR THE TREATMENT OF ULCERATIVE COLITIS

Independent blinded re-read of endoscopies provides signal of clinical efficacy and identifies human error in initial reads provided...

Elanco's IPO Would Free Eli Lilly to Focus on Pharmaceuticals

ELANCO'S IPO WOULD FREE ELI LILLY TO FOCUS ON PHARMACEUTICALS

Elanco, the animal health business of Eli Lilly, has filed for an IPO, setting in motion the process of splitting from its parent company...

 
 
 
Bio Roundup: Alnylam's Moment, Read on Rebates, Skinny Plans & More

BIO ROUNDUP: ALNYLAM'S MOMENT, READ ON REBATES, SKINNY PLANS & MORE

Millions of people might be on vacation as we hit the dog days, but drug makers and politicians aren't taking a break from the gamesmanship...

Cities that are running out of water can now safely remove at least some pharmaceuticals from recycled water and wastewater

CITIES THAT ARE RUNNING OUT OF WATER CAN NOW SAFELY REMOVE AT LEAST SOME PHARMACEUTICALS FROM RECYCLED WATER AND WASTEWATER

If cities are forced to recycle water, they'll need to find a way to filter out pharmaceuticals - such as the widely used anxiety drug...

 
 
 

EUROPEAN PATENT GRANTED FOR BIOCEPT'S TARGET SELECTOR ONCOGENE MUTATION ENRICHMENT AND DETECTION PLATFORM

Expands intellectual property to 27 issued patents globally for highly sensitive methods of detecting cancer biomarkers in circulating...

GV leads $30 million investment in Verana Health to improve clinical research using EHR data

GV LEADS $30 MILLION INVESTMENT IN VERANA HEALTH TO IMPROVE CLINICAL RESEARCH USING EHR DATA

Verana Health, a platform that's setting out to help the life sciences industry enhance clinical studies with analytics and data, has...

 
 
 

ENGINEER 1, PROCESS DEVELOPMENT - ILLUMINA - SAN DIEGO, CA

Work experience in the biotech, pharmaceutical or semiconductor industries is desirable. Construct and execute controlled experiments...

PRESBYOPIA THERAPIES ANNOUNCES PRIMARY SAFETY AND EFFICACY ENDPOINTS MET IN A PHASE IIB STUDY OF ITS TOPICAL PRX OPHTHALMIC SOLUTION FOR THE TREATMENT OF PRESBYOPIA

CORONADO, Calif., July 30, 2018 /PRNewswire/ - Presbyopia Therapies, LLC, a privately-held ophthalmic pharmaceutical company dedicated...